Relay Therapeutics Correlations

RLAY Stock  USD 7.14  0.20  2.72%   
The current 90-days correlation between Relay Therapeutics and Upstream Bio, is 0.38 (i.e., Weak diversification). The correlation of Relay Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Relay Therapeutics Correlation With Market

Weak diversification

The correlation between Relay Therapeutics and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relay Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.

Moving together with Relay Stock

  0.67PANACEABIO Panacea BiotecPairCorr
  0.88RAC Race OncologyPairCorr
  0.77VANI Vivani MedicalPairCorr
  0.64DNLI Denali TherapeuticsPairCorr
  0.63DNTH Dianthus TherapeuticsPairCorr
  0.82VCYT VeracytePairCorr
  0.91VERA Vera Therapeutics Earnings Call This WeekPairCorr
  0.87DRUG Bright Minds BiosciencesPairCorr
  0.73DRTS Alpha Tau MedicalPairCorr
  0.82CDIOW Cardio DiagnosticsPairCorr
  0.63DSGN Design Therapeutics Earnings Call This WeekPairCorr
  0.62DXB DimerixPairCorr
  0.9DTIL Precision BioSciences Downward RallyPairCorr
  0.7DWTX Dogwood Therapeutics,PairCorr
  0.74DYAI Dyadic InternationalPairCorr
  0.8VNDA Vanda Pharmaceuticals Earnings Call This WeekPairCorr
  0.94VRDN Viridian Therapeutics Sell-off TrendPairCorr

Moving against Relay Stock

  0.9DRMA Dermata TherapeuticsPairCorr
  0.34AVH Avita Medical Earnings Call This WeekPairCorr
  0.67SRZNW Surrozen WarrantPairCorr
  0.89VPRO ViroproPairCorr
  0.84300238 Guanhao BiotechPairCorr
  0.58VXRT Vaxart IncPairCorr
  0.57KTTAW Pasithea TherapeuticsPairCorr
  0.53VRAX Virax Biolabs GroupPairCorr

Related Correlations Analysis


Risk-Adjusted Indicators

There is a big difference between Relay Stock performing well and Relay Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Relay Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
UPB  3.62  0.85  0.21  2.01  3.16 
 8.48 
 25.94 
SEPN  2.63  0.78  0.31  2.39  1.91 
 6.19 
 19.14 
PRME  5.59  0.28  0.10  0.19  5.04 
 13.39 
 28.87 
NKTR  3.91  1.63  0.49  1.09  2.45 
 10.33 
 33.83 
ZBIO  5.32  1.01  0.20  0.46  5.21 
 9.50 
 40.28 
BCAX  3.47  0.50  0.14  0.40  3.57 
 8.67 
 29.35 
PRAX  7.32  3.75  0.77 (0.74) 2.87 
 9.20 
 191.57 
OCS  1.50  0.14  0.02  2.46  2.06 
 4.89 
 13.45 
TNGX  3.45  0.38  0.11  0.36  3.59 
 7.77 
 31.68 
XNCR  3.27  0.70  0.23  0.39  3.09 
 10.71 
 24.00 

Relay Therapeutics Corporate Management

Deborah PalestrantVice StrategyProfile
SooYeun LimSenior CounselProfile
MA MBAPres CEOProfile
Thomas CatinazzoChief OfficerProfile
Iain MartinSenior DevelopmentProfile
Andy PorterChief OfficerProfile